Introduction
Genetic modification using DNA vectors containing kilobases (kbs) of homology to the target locus is well established and has been used for over a decade to generate gene-targeted transgenic mice. 1 There have been several reports that only a small region of homology is necessary for gene targeting, which has led researchers to explore the possibility of gene targeting in somatic cells using short, denatured singlestranded or double-stranded DNA fragments. Short fragment homologous replacement describes a process by which a gene is altered by targeting with a homologous DNA fragment of less than 1 kb, which contains the base-pair changes required. This approach was used to correct the most common cystic fibrosis (CF) mutation, the DF508 3 bp deletion, in transformed CF epithelial cells, using a 491 bp denatured, singlestranded DNA fragment, 2 and later also in nontransformed epithelial cells. 3 In addition, early reports suggested that single-stranded oligonucleotides of only 40 bases were sufficient to achieve gene targeting on a plasmid. 4 More recently, somatic cell gene targeting has been achieved in vitro with RNA:DNA chimeric oligonucleotides [5] [6] [7] [8] double-and single-stranded PCR-generated fragments 2, 3, 9 and single-stranded oligonucleotides. Gene repair has also been reported in vivo in a variety of tissues including the liver, 10 , lung, 11 muscle, 12 and skin, 13 using a variety of fragments or oligonucleotides. Current gene therapy approaches involving addition of a gene by viral or nonviral vectors often give a short duration of gene expression and are difficult to target to specific populations of cells. Site-specific gene repair at the chromosomal locus would be an alternative strategy for gene therapy. In this approach, the targeted gene would still be regulated by its endogenous promoter, and therefore expressed at physiological levels in the appropriate cell type. By targeting gene repair to populations of stem cells, it is possible that long-term correction might be achieved through clonal expansion. One of the difficulties in assessing the feasibility of gene repair, however, is the low frequency with which it occurs in many tissues and, in some reported experiments, the lack of non-PCR-based end point assays. When high numbers of oligonucleotides are delivered, often protected against degradation by phosphorothioate or O-methyl modification, the possibility exists of PCR artefacts generated by priming of these oligonucleotides to the DNA or mRNA to produce 'corrected amplicons'. 14 It is difficult to compare the efficiency of each gene repair method used by different groups, because each experimental approach is very different. We wished to compare directly the various methods of gene repair that have been reported as successful using a lacZ reporter system similar to that described by Igoucheva et al. 15 We decided against using a PCR-based end point assay, but used restoration of b-galactosidase as an indicator of gene repair events. We have directly compared different gene repair methods in different cell types, and have also compared repair of an episomal plasmid versus repair of a chromosomal gene.
Results
We have generated a mammalian expression plasmid carrying a lacZ gene with a G to A base-pair mutation causing a Glu to Lys amino-acid substitution at position 461, rendering b-galactosidase nonfunctional (Figure 1 ). This mutation was previously used to evaluate the efficacy of RNA:DNA and single-stranded DNA oligonucleotides for gene repair. 7, 15 The mutated plasmid, pCMVM1bgeo, bears a b-galactosidase -neomycin resistance fusion gene, bgeo, which produces a fusion protein product, bGEO. Although the b-galactosidase part of this protein is not functional unless gene repair has occurred, the protein can be detected by Western blotting, and the portion of the protein conferring neomycin resistance is still functional and was used to generate stable cell lines.
Episomal gene repair
We co-transfected cells with the mutated lacZ plasmid and one of the repair molecules, using the liposomal reagent, Lipofectamine. After 48 h, cells were stained for b-galactosidase activity and blue cells counted. Initially, various molar ratios of corrective species to plasmid were tested, from 5:1 to 25:1, and optimal gene repair was achieved at a ratio of 16.7:1, that is 0.5 pmols of the fragment or oligonucleotide and 0.03 pmols of plasmid DNA. This is slightly higher than the 10:1 ratio used by Igoucheva et al. 15 The mutation on an episomal plasmid was repaired to produce functional b-galactosidase using DNA fragments ranging from oligonucleotides of 20 bases to PCR fragments of 1.9 kb in HEK293T, CHOK1, mouse embryonic stem (ES), and human bronchial epithelial (16HBE) cell lines. Relative transfection efficiencies of each cell line were determined by transfection of the b-galactosidase-expressing plasmid pCMVbgal. Efficiency of transfection ranged from 70% to 90% for HEK293T, 50 to 70% for CHOK1, and 1 to 5% for HBE and ES cell lines (Table 1) . Although transfection of a plasmid may not precisely reflect transfection of a PCR fragment or oligonucleotide, it gives an indication of the relative ease of transfection of the cell lines used in this study. The absolute rate of gene repair was determined, as well as the theoretical rate of gene repair assuming that 100% of cells could be transfected (Table 1 ).
In general, the highest rate of episomal gene repair was observed in those cell lines with the highest transfection efficiency such as the HEK293T cell line. Repair frequency was calculated as the number of cells positive for b-galactosidase activity/total number of cells. Maximum efficiencies of episomal repair ranged from 0.025% in ES cells to 20% in HEK293T cells ( Figure  3 ). PCR-generated double-stranded fragments were most effective at mediating episomal gene repair in all cell Figure 4 ). Single-stranded oligonucleotides were also successful in mediating gene repair, although in this episomal system, no difference in repair efficiency was observed between sense and antisense oligonucleotides. An RNA:DNA chimeric molecule gave no measurable episomal repair.
Chromosomal gene repair
Stable cell lines were generated by integration of pCMVM1bgeo into CHOK1 and HBE cells. As HEK293T cells already possess a neomycin-resistance gene, the plasmid pcDNA3.1zeomutlacZ (a gift from Kyonggeun Yoon) was used to generate HEK293T stable cell lines. This plasmid bears a mutation identical to that in pCMVM1bgeo. ES clones were generated by targeting the mutated bgeo sequence to the ROSA26 locus 16 by homologous recombination. NR2 cells, derived from the GtROSA26 mouse strain, show strong lacZ staining. 17 Cell lines were checked for insertion of the construct by Southern blotting, which also determined the copy number of the integrated construct. Expression of the mutant b-galactosidase or mutant bGEO fusion protein was confirmed by Western blotting (Figure 3 ). Several clones from each cell line were used in initial experiments, and as little difference in repair frequencies was observed between clones from the same cell line; two representative clones from each cell line were chosen for further studies.
HEK293T and CHOK1 stable cell lines with integrated pcDNA3.1zeomutlacZ or pCMVM1bgeo plasmids were transfected with 0.5 mg of double-stranded DNA fragments or oligonucleotides per well of a 24-well plate. Increasing the amount of DNA delivered above this amount did not increase the repair frequency of any of the fragments or oligonucleotides (data not shown). After 48 h, cells were stained for b-galactosidase activity. Chromosomal repair was detected in HEK293T and CHOK1 cell lines with a double-stranded PCR fragment or single-stranded oligonucleotide. Despite PCR fragments (0.52-1.9 kb) giving the highest frequency of gene repair of an episomal plasmid (Figure 4 ), at a chromosomal locus, short oligonucleotides of 35 or 80 bases give the highest levels of repair ( Figure 5 ) Antisense oligonucleotides were consistently at least five-fold more efficient at mediating gene repair than their sense counterparts. The 68-base RNA:DNA chimera produced no chromosomal gene repair, despite two separate syntheses of a molecule identical to that used successfully by others. 15 Levels of chromosomal gene repair with a 35-base antisense oligonucleotide ranged from around 0.036% in CHOK1 cell lines stably expressing the mutant b-galactosidase to 0.2% in HEK293T stable cell lines (Table 1) . Transfection with control fragments bearing a sequence identical to the mutant lacZ gene never restored b-galactosidase activity.
The choice of fragment and cell type both influenced the frequencies of gene repair. Chromosomal gene repair occurred at an extremely low frequency in mouse ES and HBE cell lines; therefore, no significant results were obtained in these experiments, although a few blue cells were observed in HBE cells when transfected with the 35 antisense oligonucleotide complexed with the polyethylenamine reagent ExGen500. Photographs of repaired cells are shown in (Figure 2 ).
Despite the two stable CHOK1 clones, CHOK1LZ4 and CHOK1LZ12, having different copy numbers of the target gene, (Figure 3a ) no significant difference was found in the targeting efficiency with any of the DNA fragments or oligonucleotides used.
To rule out the possibility that the effect observed was only a transient repair event, CHO-K1 stable cell lines transfected with the 35 antisense oligonucleotide were passaged, and b-galactosidase-positive cells counted at each passage. By passage 10, there was no observed decline in the number of positive cells compared to passage 1. This corresponds to about 50 cell divisions, suggesting that the gene repair event is stable. In addition to this, cells staining blue were observed in clusters, suggesting clonal expansion ( Figure 6 ).
Discussion
We have used a mutated lacZ reporter gene to evaluate the frequency of episomal and chromosomal gene repair Comparison of gene repair strategies HD Nickerson and WH Colledge using several different methods. We have confirmed that both PCR-generated fragments of a few hundred base pairs and single-stranded oligonucleotides are capable of mediating gene repair. Our estimates of gene repair frequency are based on counts of cells staining positive for b-galactosidase. However, it should be considered that this may underestimate the actual frequency of repair at the genomic locus, as we rely on repair leading to levels of b-galactosidase detectable by X-gal staining.
Several groups have used episomal plasmids to compare different gene repair strategies, 9, 18, 19 but we have shown that this may not be an appropriate model for chromosomal repair, as the relative repair frequencies of different gene repair agents differ between episomal and chromosomal targets. In particular, while a 0.52 kb PCR-generated fragment gave the highest level of episomal plasmid repair, it was the single-stranded antisense oligonucleotides of 35 or 80 bases that Comparison of gene repair strategies HD Nickerson and WH Colledge gave the highest frequencies of repair at a chromosomal locus. Our data agree with previous reports that an antisense oligonucleotide increases the frequency of chromosomal gene repair above that obtained with a sense oligonucleotide, although we recorded a difference of only 5 to 10-fold, which is considerably lower than the 1000-fold reported Igoucheva et al. 7 This difference might be caused by a transcriptional effect, as it is possible a sense oligonucleotide to be displaced from the transcribed strand of DNA by the RNA polymerase II complex during transcription. 20 More stable binding of the antisense oligonucleotide to the nontranscribed strand might account for its relatively higher frequencies of gene repair.
It is noteworthy, however, that we observed no difference between sense and antisense oligonucleotides when targeting gene repair to an episomal plasmid in mammalian cells. In contrast, one report in yeast shows clear differences in episomal gene repair frequency between sense and antisense oligonucleotides. 20 In this yeast study, the plasmid used was capable of replication in the host cell, whereas the plasmids used in this work are not replication competent in mammalian cells. Perhaps this difference may indicate that replication, in addition to transcription, is required for the sense/ antisense difference to become apparent. Also, as doublestranded PCR fragments give the highest rates of repair on this nonreplicating plasmid, this indicates that the mechanism of action of double-stranded PCR fragments is unlikely to be replication dependent.
Episomal repair frequencies appear to be 10-100 times higher than chromosomal repair frequencies in the same cell line. It should be considered that this may not reflect a difference in the efficiency of repair of a single locus, as there are likely to be a greater number of alleles per cell for episomal repair experiments compared to the stable cell lines that possess a low copy number. If more mutant alleles are repaired per cell, this may increase the chance of detecting b-galactosidase activity and give an apparently higher frequency for gene repair. However, although stable cell lines CHOK1LZ4 and CHOK1LZ12 have a different number of plasmid integrations, there is no significant difference between their repair efficiencies. An increased number of target alleles may also increase the chance of an episomal repair event occurring, especially as the introduction of the target molecule and repair vector in the same transfection complex may increase the chance of repair by ensuring close association. 
Comparison of gene repair strategies HD Nickerson and WH Colledge
Small oligonucleotides may be more efficient at bringing about chromosomal gene repair than longer, doublestranded fragments because of their small size increasing mobility in the cytoplasm and therefore access to the nucleus. 21 The greater mobility of oligonucleotides may also contribute to the relatively higher rates of episomal repair observed with PCR amplicons. As these larger DNA fragments are less mobile than small oligonucleotides in the cytoplasm, they may be more likely to remain associated with the transfected plasmid and therefore exert a higher targeting pressure.
An additional factor that influences the efficiency of gene repair is the maximum transfection efficiency of the cell line. Clearly the higher the transfection efficiency, the more likely the gene repair events will be ( Table 1 ). This will pose a challenge for somatic gene repair in vivo where transfection efficiencies are considerably lower than in vitro, and further improvements in oligonucleotide gene delivery are likely to be critical to the success of gene repair as a viable gene therapy strategy for many tissues. Although the transfection efficiency of a cell line will affect repair frequency, there are other factors, possibly the relative abundance of DNA repair proteins necessary to produce gene repair, that contribute to the differences in repair efficiency between cell lines even when transfection efficiencies have been normalized (Table 1) .
Our study has confirmed using a functional enzyme assay that gene repair of a chromosomal locus is possible using both double-stranded PCR amplicons and oligonucleotides as short as 20 bases. Using a stably integrated reporter gene, rather than an episomal plasmid, is likely to give a clearer picture of the optimal conditions for gene repair to occur. However, multiple copies of a recently integrated gene may give a different rate of gene repair to an endogenous gene, as might the high level of transcription produced by the CMV promoter used in these studies. More transcriptionally active genes may have higher rates of gene repair. Disease-causing genes may present more difficult targets for gene repair, as they may be situated in less accessible areas of the chromosome, be transcribed at much lower levels, and are generally only present as two, rather than multiple, alleles in the genome. In addition to these possible limitations, the barriers to high-efficiency gene delivery are much higher in vivo. Therefore, the repair frequencies that we have estimated in our model system are likely to be higher than those obtainable with current in vivo gene delivery methods.
Methods
Megaprimer PCR to generate mutated bgeo gene pCMVM1bgeo was generated by megaprimer PCR using primers lacZmut1rev (TAGCGCCGTGGCCTGA TTTATCCCCAGCGACCAGATGAT) and EcoRVfor Successful chromosomal gene repair was only achieved in HBE cells using the ExGen500 (TCS Cellworks) polyethylenimine reagent. A ratio of 5 nitrogen to DNA phosphate grouping (2.75 ml ExGen500/1 mg DNA) was used to deliver 0.3 mg DNA/well of a 70% confluent 24-well plate.
Generation of stable cell lines
Approximately 3 Â 10 5 cells were seeded onto a 10 cm diameter plate 24 h prior to transfection. Each plate was transfected, as above, with 10 mg of pCMV1bgeo (HBE, CHOK1) or pcDNA3.1zeomutlacZ (HEK293T). Stable HEK293T cell lines were generated using this plasmid as they already contain a neo R gene, used for selection in pCMVM1bgeo. Cells were split into single cell density and selected in either 250 mg/ml G418 (Sigma), or 250 mg/ml Zeocin (Invitrogen).
Southern blotting
Genomic DNA was digested with the appropriate restriction enzyme, fragments separated 16 h on a 0.75% agarose gel, and blotted onto Hybond N+ nylon membrane (Amersham Biosciences) using alkaline transfer. DNA probes were prepared by labelling 25 ng of gelpurified DNA fragment (600 bp neomycin fragment prepared by PCR with primers 323 (GAAGAACTCGT CAAGAAGGCGATAGAA) and 784 (GGGTGGA GAGGCTATTCGGCTAT) and PCR cycle (951C 5min, (931C 0.5 min, 631C 0.5 min, 721C 1 min) Â 39, 721C 5 min). This fragment was labelled with [a 32 P]dCTP (Amersham Biosciences) using the Rediprime II random prime labelling system (Amersham Biosciences) with overnight incubation at room temperature. Membranes were prehybridized for 2 h in 0.2 ml/cm 2 prehybridization solution: Denhardt's based buffer (5 Â SSC, 5 Â Denhardt's reagent, 0.5% SDS and 100 mg/ml denatured salmon sperm DNA) at 651C. Probes were denatured by boiling for 5 min, then transferring to wet ice for 5 min, and 25 ml of probe was added to the same buffer used for prehybridisation. Probes were hybridized for 14-16 h at
Comparison of gene repair strategies HD Nickerson and WH Colledge 651C. Membranes were then washed twice in 2 Â SSC, 0.1% SDS for 10 min at room temperature, 1 Â SSC, 0.1% SDS for 15 min at room temperature, followed by 0.1 Â SSC, 0.1% SDS at 651C until background emission was less than 10 cpm. Radioactive bands were visualized by autoradiography.
Immunoprecipitation and Western blotting
One confluent 10 cm diameter plate of cells was rinsed in ice-cold phosphate-buffered saline (PBS) and then scraped into 1 ml ice-cold PBS. After centrifugation, the pellet was resuspended in 400 ml of cold IPH buffer (0.5% NP40, 50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM EDTA with one protease inhibitor cocktail tablet (Roche) per 50 ml buffer.
Cells were lysed on ice for 20 min and lysates clarified by centrifugation for 1 min at 13 000 rpm. The supernatant was used for immunoprecipitation with a mouse monoclonal anti-b-galactosidase antibody (1:1 000 dilution) (Promega). Complexes were allowed to form at 41C for 16 h and precipitated for 2 h at 41C by the addition of Protein A/Protein G sepharose beads (Amersham Biosciences) resuspended in 20% ethanol. Beads were washed three times with cold IPH buffer. In all, 15 ml of 4 Â Laemmli buffer (0.25 M Tris pH 7.4, 2.5% SDS, 25% bmercaptoethanol, 40% glycerol) was added to the washed pellet and the precipitates boiled for 5 min before loading on a 7.5% acrylamide gel. Gels were transferred onto Amersham ECL nitrocellulose membrane, using a semidry blotter (BioRad), for 1 h at 200 mA constant current. Filters were blocked for 1 h at room temperature in PBS/0.1% Tween 20 and probed at 41C overnight with 1/10 000 mouse monoclonal anti-bgalactosidase antibody (Promega). Blots were washed, probed for 45 min with a 1/60 000 dilution of anti-mouse HRP (Sigma), and the ECL plus system (Amersham) was used for visualization.
Oligonucleotides and fragments
All DNA oligonucleotides and the RNA:DNA chimeric oligonucleotide were synthesized and HPLC purified by Cruachem Ltd (Glasgow). PCR-generated fragments were produced using Herculase proofreading polymerase (Stratagene) and purified by gel extraction using either a QIAquick gel extraction kit (QIAgen) or a GeneClean II kit (BioGene).
Assessment of gene repair efficiency
The efficiency of gene repair was visualized by staining cells (fixed with 4% paraformaldehyde for 10 min) overnight at 371C in X-gal staining solution (5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl 2 in PBS with 1 mg/ml of 5-bromo-4-chloro-3-indolyl-b-D-galactoside added just before use). Blue cell counts were estimated on a 1 mm grid giving a count of blue cells/mm 2 , or for chromosomal transfections, where gene repair occurred at a much lower frequency, all blue cells in one well of a 24-well plate were counted. Each transfection was performed in duplicate (two wells) and the experiment was repeated a minimum of five times to give an accurate estimate of repair efficiency. An average for the two wells was taken as the estimated value for the experiment and data from multiple experiments were pooled to give a final estimation of gene repair efficiency for each combination of gene repair method and cell type.
Statistics
Data were analyzed using the Kruskall-Wallis nonparametric ANOVA test.
